Georgina V. Long
Melanoma Institute Australia
89 papers found
Refreshing results…
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
UploadCombined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Download from www.nature.comAdjuvant pembrolizumab versus placebo in resected stage III melanoma.
UploadMissing publications? Search for publications with a matching author name.